关注
Calvin Young
Calvin Young
Canada's Drug Agency
在 cda-amc.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Propranolol for post-traumatic stress disorder: A review of clinical effectiveness
C Young, R Butcher
232020
Ivermectin for Parasitic Skin Infections of Lice: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness, and Guidelines
C Young, C Argáez
Canadian Agency for Drugs and Technologies in Health, 2019
21*2019
Canine and equine therapy for mental health: A review of clinical effectiveness
C Young, J Horton
192019
The Canadian medical imaging inventory, 2017
A Sinclair, A Morrison, C Young, L Pyke
Ottawa: CADTH, 2018
172018
Management and Treatment of Cervicitis: A Review of Clinical Effectiveness and Guidelines [Internet]
C Young, C Argáez
Canadian Agency for Drugs and Technologies in Health, 2017
142017
Manual Therapy for Chronic Non-Cancer Back and Neck Pain: A Review of Clinical Effectiveness
C Young, C Argáez
112020
Internet-delivered cognitive behavioural therapy for major depression and anxiety disorders: a review of clinical effectiveness
C Young, K Campbell, C Dulong
82019
Room service food delivery models for hospital in-patients: A review of clinical effectiveness, cost-effectiveness, and guidelines
C Young, K Farrah
72019
Internet-delivered cognitive behavioral therapy for post-traumatic stress disorder: A review of clinical effectiveness
C Young, K Campbell
72019
Fetal scalp lactate testing during intrapartum pregnancy with abnormal fetal heart rate: A review of clinical effectiveness, cost-effectiveness, and guidelines
C Young, A Ryce
72018
An investigation of the pH dependence of copper-substituted anthrax lethal factor and its mechanistic implications
CJ Young, K Richard, A Beruar, SY Lo, S Siemann
Journal of Inorganic Biochemistry 182, 1-8, 2018
62018
Highly dynamic metal exchange in anthrax lethal factor involves the occupation of an inhibitory metal binding site
CJ Young, S Siemann
Chemical Communications 52 (79), 11748-11751, 2016
62016
Rapid genome-wide testing: a review of clinical utility, cost-effectiveness, and guidelines
C Young, C Argáez
52019
Rituximab for the treatment of myasthenia gravis: a 2021 update
C Young, SC McGill
Canadian Journal of Health Technologies 1 (4), 2021
42021
Rituximab for the Treatment of Myasthenia Gravis: A 2021 Update [Internet]
C Young, SC McGill
Canadian Agency for Drugs and Technologies in Health, 2021
42021
Convalescent Plasma Therapy for the Treatment of COVID-19: A Review of Clinical Effectiveness
A Subramonian, C Young, H Loshak, S McCormack, M Clark
Canadian Agency for Drugs and Technologies in Health, 2021
42021
N-Acetylcysteine Instillation during bronchoscopy for patients requiring non-cystic fibrosis-related mucus secretion clearance: a review of clinical effectiveness and guidelines
C Young, S McCormack
42019
An Overview of Pharmacogenomic Testing for Psychiatric Disorders
C Young, D MacDougall
Canadian Journal of Health Technologies 3 (6), 2023
32023
Flash glucose monitoring systems in pediatric populations with diabetes
C Young, A Grobelna
Canadian Journal of Health Technologies 1 (4), 2021
32021
Elevated vacuum suspension systems for adults with amputation: A review of clinical effectiveness, cost-effectiveness, and guidelines
C Young, H Loshak
Canadian Agency for Drugs and Technologies in Health, 2020
32020
系统目前无法执行此操作,请稍后再试。
文章 1–20